ATOS Atossa Genetics Timely for Second Half Bullish Run and possible position trade

ATOS Atossa genetics is a biotech medical device company. Their product is a device that tests for early signs of cancer in women and they are trying to create a new paradigm of testing that replaces the current standard 38 million mammograms done each year.  From what I have learned so far mammograms are less … Read more

Is it prime time for NGAS?

I first mentioned NGAS on February 10th, and then on February 25th. Since February 10th, NGAS has appreciated about 23%. The overall chart on a long term as well as short term time frame still has promise. When I first mentioned this stock I made the statement that symmetrical triangle stock chart patterns are not … Read more